| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |